Bruker Corp
BRKR44.960USD
-0.710-1.55%
Cierre 12/16, 16:00（ET）Cotizaciones retrasadas 15 min
6.81BCap. mercado
PérdidaP/E TTM
Más Datos de Bruker Corp Compañía
Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Información de Bruker Corp
Símbolo de cotizaciónBRKR
Nombre de la empresaBruker Corp
Fecha de salida a bolsaAug 04, 2000
Director ejecutivoPrause (Burkhard A)
Número de empleados11396
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 04
Dirección40 Manning Rd
CiudadBILLERICA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01821-3915
Teléfono19786633660
Sitio Webhttps://www.bruker.com/
Símbolo de cotizaciónBRKR
Fecha de salida a bolsaAug 04, 2000
Director ejecutivoPrause (Burkhard A)
Ejecutivos de Bruker Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+0.08%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
+24.98%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
85.88K
+6.15%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+41.65%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+35.29%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
31.91K
+13.38%
Dr. Hermann Fritz Requardt, Ph.D.
Dr. Hermann Fritz Requardt, Ph.D.
Independent Director
Independent Director
23.15K
-3.83%
Ms. Adelene Q. Perkins
Ms. Adelene Q. Perkins
Independent Director
Independent Director
21.33K
-4.14%
Dr. Cynthia M. Friend, Ph.D.
Dr. Cynthia M. Friend, Ph.D.
Independent Director
Independent Director
14.72K
+5.48%
Ms. Bonnie H. Anderson
Ms. Bonnie H. Anderson
Independent Director
Independent Director
10.03K
-8.41%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+0.08%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
+24.98%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
85.88K
+6.15%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+41.65%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+35.29%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
31.91K
+13.38%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Product
634.70M
79.60%
Product And Service Other
162.70M
20.40%
Service and other revenue
162.70M
20.40%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
222.90M
27.95%
Rest of Europe
213.40M
26.76%
Rest of Asia Pacific
127.40M
15.98%
China
114.70M
14.38%
Other
59.90M
7.51%
Germany
59.10M
7.41%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Product
634.70M
79.60%
Product And Service Other
162.70M
20.40%
Service and other revenue
162.70M
20.40%
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Laukien (Frank H)
26.60%
Orbis Investment Management Ltd.
9.31%
Fidelity Management & Research Company LLC
7.52%
The Vanguard Group, Inc.
6.83%
Pallas Capital Advisors LLC
6.24%
Otro
43.50%
Accionistas
Accionistas
Proporción
Laukien (Frank H)
26.60%
Orbis Investment Management Ltd.
9.31%
Fidelity Management & Research Company LLC
7.52%
The Vanguard Group, Inc.
6.83%
Pallas Capital Advisors LLC
6.24%
Otro
43.50%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
50.95%
Individual Investor
31.97%
Investment Advisor/Hedge Fund
25.95%
Hedge Fund
8.24%
Research Firm
2.61%
Pension Fund
1.17%
Sovereign Wealth Fund
0.76%
Bank and Trust
0.38%
Insurance Company
0.21%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
887
137.27M
94.12%
+111.45K
2025Q3
908
137.16M
94.45%
+8.73M
2025Q2
904
127.18M
89.58%
+1.13M
2025Q1
886
125.13M
85.85%
-5.11M
2024Q4
855
125.47M
82.99%
+4.02M
2024Q3
812
120.93M
80.76%
+2.25M
2024Q2
782
118.65M
76.64%
+5.15M
2024Q1
766
113.09M
82.81%
-916.64K
2023Q4
748
112.27M
83.16%
-472.55K
2023Q3
723
112.40M
83.64%
-8.12M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Laukien (Frank H)
40.41M
26.64%
+31.93K
+0.08%
Aug 15, 2025
Orbis Investment Management Ltd.
4.68M
3.08%
+4.68M
--
Jun 30, 2025
Fidelity Management & Research Company LLC
7.47M
4.92%
-2.35M
-23.89%
Jun 30, 2025
The Vanguard Group, Inc.
10.40M
6.86%
-122.86K
-1.17%
Jun 30, 2025
Pallas Capital Advisors LLC
9.50M
6.26%
+5.56K
+0.06%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.40M
6.2%
-803.98K
-7.88%
Jun 30, 2025
Laukien (Joerg C)
7.52M
4.95%
--
--
Apr 01, 2025
T. Rowe Price Investment Management, Inc.
11.43M
7.53%
-952.71K
-7.69%
Jun 30, 2025
State Street Investment Management (US)
3.78M
2.49%
-42.78K
-1.12%
Jun 30, 2025
Edmond de Rothschild Asset Management (France) S.A.
1.51M
0.99%
+1.51M
--
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
First Trust NYSE Arca Biotechnology Index Fund
3.71%
ProShares Nanotechnology ETF
3.34%
State Street SPDR S&P Kensho Future Security ETF
1.27%
Ballast Small/Mid Cap ETF
1.13%
AB Disruptors ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
0.57%
iShares Health Innovation Active ETF
0.4%
iShares Biotechnology ETF
0.36%
JPMorgan Active Small Cap Value ETF
0.31%
Ver más
First Trust NYSE Arca Biotechnology Index Fund
Proporción3.71%
ProShares Nanotechnology ETF
Proporción3.34%
State Street SPDR S&P Kensho Future Security ETF
Proporción1.27%
Ballast Small/Mid Cap ETF
Proporción1.13%
AB Disruptors ETF
Proporción0.63%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
Proporción0.57%
iShares Health Innovation Active ETF
Proporción0.4%
iShares Biotechnology ETF
Proporción0.36%
JPMorgan Active Small Cap Value ETF
Proporción0.31%
Dividendos
Un total de
138.20M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 04, 2025
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025
Dec 08, 2025
Jan 02, 2026
Dec 08, 2025
Aug 12, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025
Sep 23, 2025
Oct 03, 2025
Sep 23, 2025
May 15, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jun 27, 2025
Jun 16, 2025
Feb 21, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 28, 2025
Mar 17, 2025
Nov 18, 2024
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024
Dec 02, 2024
Dec 16, 2024
Dec 02, 2024
Aug 14, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024
Sep 02, 2024
Sep 16, 2024
Aug 30, 2024
May 15, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024
Jun 03, 2024
Jun 17, 2024
Jun 03, 2024
Feb 16, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 20, 2023
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
Aug 14, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 15, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 15, 2023
Aug 31, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Bruker Corp?
Los cinco principales accionistas de Bruker Corp son:
Laukien (Frank H) posee 40.41M acciones, lo que representa el 26.64% del total de acciones.
Orbis Investment Management Ltd. posee 4.68M acciones, lo que representa el 3.08% del total de acciones.
Fidelity Management & Research Company LLC posee 7.47M acciones, lo que representa el 4.92% del total de acciones.
The Vanguard Group, Inc. posee 10.40M acciones, lo que representa el 6.86% del total de acciones.
Pallas Capital Advisors LLC posee 9.50M acciones, lo que representa el 6.26% del total de acciones.
Laukien (Frank H) posee 40.41M acciones, lo que representa el 26.64% del total de acciones.
Orbis Investment Management Ltd. posee 4.68M acciones, lo que representa el 3.08% del total de acciones.
Fidelity Management & Research Company LLC posee 7.47M acciones, lo que representa el 4.92% del total de acciones.
The Vanguard Group, Inc. posee 10.40M acciones, lo que representa el 6.86% del total de acciones.
Pallas Capital Advisors LLC posee 9.50M acciones, lo que representa el 6.26% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Bruker Corp?
Los tres principales tipos de accionista de Bruker Corp son:
Laukien (Frank H)
Orbis Investment Management Ltd.
Fidelity Management & Research Company LLC
Laukien (Frank H)
Orbis Investment Management Ltd.
Fidelity Management & Research Company LLC
¿Cuántas instituciones poseen acciones de Bruker Corp (BRKR)?
A fecha de 2025Q4, 887 instituciones poseen acciones de Bruker Corp, con un valor de mercado combinado de aproximadamente 137.27M, lo que representa el 94.12% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.33%.
¿Cuál es la mayor fuente de ganancias de Bruker Corp?
El FY2025Q2, el segmento empresarial Product generó la ganancia más alta para Bruker Corp, ascendiendo a 634.70M y representando el 79.60% de la ganancia total.
